The Independent24d
Daily pill on NHS offers new hope for hundreds with lung cancer
The drug Osimertinib (Tagrisso), developed by AstraZeneca, has been shown to double survival time in specific cases and will now be routinely available following a recommendation from the National ...
The Sun24d
Daily pill which doubles survival for UK’s biggest cancer killler to be made routinely available on the NHS
Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from returning after surgery when taken with chemotherapy. It has been recommended by the National Institute for ...
Medpage Today on MSN4mon
FDA Expands Approval of Osimertinib in Lung Cancer
The FDA has approved osimertinib (Tagrisso) for locally advanced, unresectable stage III non-small cell lung cancer (NSCLC) ...
PharmaTimes24d
EC approves lazertinib in combination with amivantamab for NSCLC patients
The approval is based on the phase 3 MARIPOSA study, which showed that the combination therapy demonstrated superior overall survival compared to the current standard treatment, osimertinib ...
London Evening Standard24d
Daily pill for lung cancer to be made routinely available on the NHS
According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific mutations. Osimertinib can help stop cancer from returning after surgery when ...